PTGX vs RSG · rev $269.8M vs P/E 36, rev $9.78B
Protagonist Therapeutics Inc (PTGX) versus Republic Services Inc (RSG) — a side-by-side from cached financials, not a winner call.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Republic Services Inc (RSG) is a waste management company listed on US.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
Latest reported RSG revenue for 2026-06-30 was $9.78B. Net income was $1.09B. RSG currently screens at market cap $75.36B and trailing P/E 36.4.
PTGX currently screens at market cap $7.25B. RSG currently screens at market cap $75.36B and trailing P/E 36.4.
Not investment advice. Open the PTGX and RSG stock pages for the full models.
Not investment advice.